Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Blog Pricing

Eli Lilly in Podcasts

company

Eli Lilly is a pharmaceutical company involved in drug development and AI collaborations.

AI biotech company health innovator medications pharma pharmaceutical pharmaceuticals US disease_treatment (0.800000011920929) drug (0.800000011920929) healthcare (0.800000011920929) weight_loss (0.800000011920929)

Mentions Over Time

25 mentions
6 related entities

Related Entities

Food and Drug Administration

founded

Eli Lilly

employed_by

Eli Lilly

founded

Eli Lilly

owned_by

Google DeepMind

collaborates_with

retitrutide

employed_by

Mentions in Podcasts

Bloomberg Talks
Novo Nordisk President and CEO Talks Wegovy Pill

Given that you expect to start selling the pill version of Wegovy in January, whereas Eli Lilly isn't due on the market until March, how do you plan to make the most of this head start?

Bloomberg Talks
Novo Nordisk President and CEO Talks Wegovy Pill

market, you've been losing share to your rival, Eli Lilly, for a couple years now.

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

Let's run through some headlines, starting with Eli Lilly and Novo Nordisk.

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

We'll also discuss the latest lawsuit that Eli Lilly and Nova Nordisk are facing regarding their GLP-1 dominance.

The Daily AI Show
We Demo Claude Cowork & Other AI News

NVIDIA and EI Lilly announced a joint AI lab for drug discovery and development.

WSJ What’s News
What’s News in Markets: AI Deals, Trump on Pharma, Banks Split

Pharma stocks Novo Nordisk and Eli Lilly really needed a shot in the arm after comments from President Trump the day before sent their shares falling.

Wall Street Breakfast
IBM to buy Confluent in further AI push

Eli Lilly, Pfizer, and Johnson & Johnson have secured spots on China's first innovative drug catalog for private insurance, a program designed to expand access to high-cost therapies.